Qube Research & Technologies LTD Aligos Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.71 - $1.06 $1 - $2	2 New	2 $0
Q3 2022 Nov 14, 2022	SELL	$1.06 - $27.5 $2,817 - $73,095	-2,658 Reduced 14.22%	16,031 $18,000
Q2 2022 Aug 15, 2022	BUY	$1.04 - $2.14 $19,436 - $39,994	18,689 New	18,689 $23,000
Q3 2021 Nov 12, 2021	SELL	$14.57 - $17.72 $222,003 - $269,999	-15,237 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$20.3 - $33.6 $2,740 - $4,536	135 Added 0.89%	15,237 $311,000
Q1 2021 May 14, 2021	BUY	$19.1 - $34.94 $288,448 - $527,663	15,102 New	15,102 $343,000

227K

Ticker ALGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,717,000
Market Cap $1.66B
Description
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.